{"id":251912,"date":"2020-11-02T00:00:00","date_gmt":"2020-11-02T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/products\/research-reports\/report\/epidcg0077-biopharma-mild-cognitive-impairment-epidemiology\/"},"modified":"2026-05-09T23:21:19","modified_gmt":"2026-05-09T23:21:19","slug":"epidcg0077-biopharma-mild-cognitive-impairment-epidemiology-emerging-markets","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/epidcg0077-biopharma-mild-cognitive-impairment-epidemiology-emerging-markets\/","title":{"rendered":"Mild Cognitive Impairment – Epidemiology – Emerging Markets"},"content":{"rendered":"

<\/a><\/p>\n

Bischkopf J, et al. Mild cognitive impairment–a review of prevalence, incidence and outcome according to current approaches. Acta Psychiatr Scand<\/i>. 2002;106:403-414 [PUBMED] <\/a><\/p>\n

Bruscoli M, et al. Is MCI really just early dementia? A systematic review of conversion studies. Int Psychogeriatr<\/i>. 2004;16:129-140 [PUBMED] <\/a><\/p>\n

Ding D, et al. Prevalence of mild cognitive impairment in an urban community in China: a cross-sectional analysis of the Shanghai Aging Study. Alzheimers Dement<\/i>. 2015;11:300-309 [PUBMED] <\/a><\/p>\n

Dlugaj M, et al. Prevalence of mild cognitive impairment and its subtypes in the Heinz Nixdorf Recall study cohort. Dement Geriatr Cogn Disord<\/i>. 2010;30:362-373 [PUBMED] <\/a><\/p>\n

Gonz\u00e1lez HM, et al. Prevalence and correlates of mild cognitive impairment among diverse Hispanics\/Latinos: Study of Latinos-Investigation of Neurocognitive Aging results. Alzheimers Dement<\/i>. 2019;15(12):1507-1515. [PUBMED]<\/a><\/p>\n

Janelidze M, et al. Mild Cognitive Impairment in Republic of Georgia. Gerontol Geriatr Med<\/i>. 2018;4:2333721418771408. [PUBMED]<\/a><\/p>\n

Juarez-Cedillo T, et al. Prevalence of mild cognitive impairment and its subtypes in the Mexican population. Dement Geriatr Cogn Disord<\/i>. 2012;34:271-281 [PUBMED] <\/a><\/p>\n

Katz MJ, et al. Age-specific and sex-specific prevalence and incidence of mild cognitive impairment, dementia, and Alzheimer dementia in blacks and whites: a report from the Einstein Aging Study. Alzheimer Dis Assoc Disord<\/i>. 2012;26:335-343 [PUBMED] <\/a><\/p>\n

Kim KW, et al. A nationwide survey on the prevalence of dementia and mild cognitive impairment in South Korea. J Alzheimers Dis<\/i>. 2011;23:281-291 [PUBMED]<\/a><\/p>\n

Lara E, Koyanagi A, Olaya B, et al. Mild cognitive impairment in a Spanish representative sample: prevalence and associated factors. Int J Geriatr Psychiatry<\/i>. 2016;31(8):858-867. [PUBMED]<\/a><\/p>\n

Lee LK, et al. Prevalence of gender disparities and predictors affecting the occurrence of mild cognitive impairment (MCI). Arch Gerontol Geriatr<\/i>. 2012;54:185-191 [PUBMED] <\/a><\/p>\n

Lopez OL, et al. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Arch Neurol<\/i>. 2003;60:1385-1389 [PUBMED] <\/a><\/p>\n

Luck T, et al. Mild cognitive impairment in general practice: age-specific prevalence and correlate results from the German study on ageing, cognition and dementia in primary care patients (AgeCoDe). Dement Geriatr Cogn Disord<\/i>. 2007;24:307-316 [PUBMED] <\/a><\/p>\n

Ma F, et al. Prevalence of Mild Cognitive Impairment and Its Subtypes among Chinese Older Adults: Role of Vascular Risk Factors. Dement Geriatr Cogn Disord<\/i>. 2016;41(5-6):261-272. [PUBMED]<\/a><\/p>\n

Manly JJ, et al. Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol<\/i>. 2008;63:494-506 [PUBMED] <\/a><\/p>\n

Mohan D, Iype T, Varghese S, Usha A, Mohan M. A cross-sectional study to assess prevalence and factors associated with mild cognitive impairment among older adults in an urban area of Kerala, South India. BMJ Open<\/i>. 2019;9(3):e025473. [PUBMED]<\/a><\/p>\n

Moretti F, et al. Prevalence and characteristics of mild cognitive impairment in the general population. Data from an Italian population-based study: The Faenza Project. Aging Ment Health<\/i>. 2013;17:267-275 [PUBMED] <\/a><\/p>\n

Ogunniyi A, et al. Prevalence estimates of major neurocognitive disorders in a rural Nigerian community. Brain Behav<\/i>. 2016;6(7):e00481 [PUBMED]<\/a><\/p>\n

Overton M, et al. Prevalence and Incidence of Mild Cognitive Impairment across Subtypes, Age, and Sex. Dement Geriatr Cogn Disord<\/i>. 2019;47(4-6):219-232 [PUBMED]<\/a><\/p>\n

Parlevliet JL, et al. Prevalence of mild cognitive impairment and dementia in older non-western immigrants in the Netherlands: a cross-sectional study. Int J Geriatr Psychiatry<\/i>. 2016;31(9):1040-1049 [PUBMED]<\/a><\/p>\n

Petersen RC, et al. Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging. Neurology<\/i>. 2010;75:889-897 [PUBMED] <\/a><\/p>\n

Ravaglia G, et al. Mild cognitive impairment: epidemiology and dementia risk in an elderly Italian population. J Am Geriatr Soc<\/i>. 2008;56:51-58 [PUBMED]<\/a><\/p>\n

Roberts RO, et al. The incidence of MCI differs by subtype and is higher in men: the Mayo Clinic Study of Aging. Neurology<\/i>. 2012;78:342-351 [PUBMED]<\/a><\/p>\n

Saikia A Moni, Rajendran V. Prevalence and Risk Factors of Mild Cognitive Impairment (MCI) among the Elderly of Guwahati City, Assam: A Cross-sectional Study. International Journal of Medicine and Public Health. 2020;10(2):77-80. [LINK]<\/a><\/p>\n

Sun Y, et al. A nationwide survey of mild cognitive impairment and dementia, including very mild dementia, in Taiwan. PLoS One<\/i>. 2014;9:e100303 [PUBMED] <\/a><\/p>\n

United Nations. Department of Economic and Social Affairs. Population Division. World Population Prospects. 2015. [LINK]<\/a><\/p>\n

Wada-Isoe K, et al. Prevalence of Dementia and Mild Cognitive Impairment in the Rural Island Town of Ama-cho, Japan. Dement Geriatr Cogn Dis Extra<\/i>. 2012;2:190-199 [PUBMED]<\/a><\/p>\n

Winblad B, et al. Mild cognitive impairment–beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004 Sep;256(3):240-6 [PUBMED]<\/a><\/p>\n

Wu L, et al. The association between the prevalence, treatment and control of hypertension and the risk of mild cognitive impairment in an elderly urban population in China. Hypertens Res<\/i>. 2016;39(5):367-375 [PUBMED]<\/a><\/p>\n

Yang L, et al. Prevalence of dementia, cognitive status and associated risk factors among elderly of Zhejiang province, China in 2014. Age Ageing<\/i>. 2016;45(5):708-712 [PUBMED]<\/a><\/p>\n","protected":false},"template":"","class_list":["post-251912","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-mild-cognitive-impairment","biopharma-therapy-areas-neurology","biopharma-product-epidemiology","biopharma-date-942"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251912","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":10,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251912\/revisions"}],"predecessor-version":[{"id":581461,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251912\/revisions\/581461"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=251912"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}